Literature DB >> 29372517

MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.

Chunhua Yan1, Wei Zhang2, Xiaodong Shi3, Jiaolin Zheng3, Xiaoming Jin4, Jianmin Huo5.   

Abstract

MicroRNAs (miRNAs) have been shown to be critical regulators in many types of tumors. The aim of our study was to investigate the role of miR-760 in non-small cell lung cancer (NSCLC). We demonstrated that the expression of miR-760 was downregulated in NSCLC tissues compared with the adjacent normal tissues. We also demonstrated that the expression of miR-760 was downregulated in the NSCLC cell lines. Overexpression of miR-760 suppressed the NSCLC cell proliferation, cell cycle, and migration. Moreover, we identified that ROS1 was a direct target of miR-760 in the NSCLC cell. Elevated expression of miR-760 suppressed ROS1 expression in the NSCLC cell. We also demonstrated that the expression of ROS1 was higher in the NSCLC tissues than in the adjacent lung tissues. MiR-760 expression level was reversely associated with the expression level of ROS1 in the NSCLC tissues. In summary, we showed that miR-760 suppressed the NSCLC cell proliferation, cell cycle, and migration through regulating the ROS1 expression. These data suggested that miR-760 may act as a tumor suppressor gene in the NSCLC partly through regulating ROS1 expression.

Entities:  

Keywords:  MiR-760; MicroRNAs; Non-small cell lung cancer; ROS1

Mesh:

Substances:

Year:  2018        PMID: 29372517     DOI: 10.1007/s11356-017-1138-0

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  17 in total

1.  Linc01133 promotes proliferation and metastasis of human renal cell carcinoma through sponging miR-760.

Authors:  Wei Lv; Yan Li; Liye Fu; Fandong Meng; Jun Li
Journal:  Cell Cycle       Date:  2022-04-21       Impact factor: 5.173

2.  Prognostic role of miR-760 in hepatocellular carcinoma.

Authors:  Dong Sun; Jinghui Lu; Chunxiao Hu; Qiangbo Zhang; Xiangdong Wang; Zongli Zhang; Sanyuan Hu
Journal:  Oncol Lett       Date:  2018-10-03       Impact factor: 2.967

3.  LncRNA NR_003923 promotes cell proliferation, migration, fibrosis, and autophagy via the miR-760/miR-215-3p/IL22RA1 axis in human Tenon's capsule fibroblasts.

Authors:  Yang Zhao; Feng Zhang; Zheng Pan; Haomin Luo; Ke Liu; Xuanchu Duan
Journal:  Cell Death Dis       Date:  2019-08-07       Impact factor: 9.685

4.  LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis.

Authors:  Kai Guo; Di Qi; Bo Huang
Journal:  Cancer Cell Int       Date:  2021-02-01       Impact factor: 5.722

5.  Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis.

Authors:  Xin Lv; Yingjie Lian; Zhanye Liu; Jianguang Xiao; Donghua Zhang; Xiaohua Yin
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

Review 6.  Small RNAs, Big Diseases.

Authors:  Iwona Rzeszutek; Aditi Singh
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

7.  Long Noncoding RNA FOXD2-AS1 Promotes the Malignancy of Cervical Cancer by Sponging MicroRNA-760 and Upregulating Hepatoma-Derived Growth Factor.

Authors:  Xiaoqing Dou; Qun Zhou; Mingxiao Wen; Jiangyan Xu; Yingping Zhu; Shuzhen Zhang; Xianli Xu
Journal:  Front Pharmacol       Date:  2020-01-31       Impact factor: 5.810

8.  Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression.

Authors:  Ruofeng Yin; Junzhi Liu; Dongxu Zhao; Fei Wang
Journal:  Onco Targets Ther       Date:  2020-03-13       Impact factor: 4.147

9.  MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription.

Authors:  Liang Ge; Yu Wang; Quan-Hong Duan; Song-Shan Liu; Guo-Jing Liu
Journal:  World J Gastroenterol       Date:  2019-12-07       Impact factor: 5.742

10.  miR‑760 regulates skeletal muscle proliferation in rheumatoid arthritis by targeting Myo18b.

Authors:  Xujun Tang; Jiuxia Wang; Shuhong Zhou; Jing Zhou; Guyou Jia; Han Wang; Chunlei Xin; Guoning Fu; Jiahong Zhang
Journal:  Mol Med Rep       Date:  2019-10-29       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.